Developmental venous anomalies in patients with multiple sclerosis: is that a coincidence or an ancillary finding?

Irene GrazziniBenedetta CalchettiGian Luca Cuneo

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)

DVAs demonstrated a higher prevalence in the MS group in comparison to controls. We confirmed the association between DVAs and FLAIR anomalies in MS patients. However, currently there are no evidences that the presence of DVAs may be used in MS differential diagnosis.

Keyphrases

mass spectrometry
multiple sclerosis
ms ms
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
risk factors
prognostic factors
peritoneal dialysis
patient reported outcomes
patient reported